Immunometabolic Reprogramming in Experimental Sepsis: A Driver of Multiple Organ Dysfunction Syndrome
Journal of Inflammation Research · 2026-03 · Volume 19 · 1-25
DOI: 10.2147/jir.s577143 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-03. Verfasst von Fan Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Special Education College, Beijing Union University, Beijing, People's Republic of China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening syndrome characterized by infection-induced systemic inflammation and immune dysregulation, commonly resulting in the development of multiple organ dysfunction syndrome (MODS), a leading cause of mortality in clinical practice. In decades, immunometabolic reprogramming has been identified as a critical mechanism that contributes to the progression of sepsis and the associated organ injuries. The review provides a systematic overview of the metabolic alterations in immune cells and organs in experimental models of sepsis. Key features include enhanced glycolysis, impaired mitochondrial function, and disturbed lipid metabolism, all of which are closely associated with organ damage. These metabolic adaptations influence immune responses and cell fate decisions, inter-organ crosstalk, and the development of MODS. A detailed examination is conducted on the temporal progression of pathological changes in established animal models, along with organ-specific metabolic dysfunctions and novel therapeutic targets. It emphasizes the importance of dynamic immunometabolic regulation, tissue-specific responses, and inter-organ interactions in the context of sepsis treatment. The integration of multi-omics technologies, identification of reliable biomarkers, and the development of personalized therapeutic strategies should be used to facilitate clinical translation of mechanistic insights.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Special Education College, Beijing Union University, Beijing, People's Republic of China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
Zitieren
APA
Wu, F., Chen, Y., Chen, L., Wei, X., Zhang, L., & Shen, Y. (2026). Immunometabolic Reprogramming in Experimental Sepsis: A Driver of Multiple Organ Dysfunction Syndrome. Journal of Inflammation Research, Volume 19, 1-25. https://doi.org/10.2147/jir.s577143
Vancouver
Wu F, Chen Y, Chen L, Wei X, Zhang L, Shen Y. Immunometabolic Reprogramming in Experimental Sepsis: A Driver of Multiple Organ Dysfunction Syndrome. Journal of Inflammation Research. 2026;Volume 19:1-25. doi:10.2147/jir.s577143
BibTeX
@article{Wu2026,
author = {Wu, Fan and Chen, Yantong and Chen, Lihua and Wei, Xiaolu and Zhang, Lin and Shen, Yi},
title = {Immunometabolic Reprogramming in Experimental Sepsis: A Driver of Multiple Organ Dysfunction Syndrome},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--25},
doi = {10.2147/jir.s577143}
}
EUVIMED